Follow
Gerard Sanacora
Gerard Sanacora
Professor of Psychiatry, Yale University
Verified email at yale.edu - Homepage
Title
Cited by
Cited by
Year
The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission
M Popoli, Z Yan, BS McEwen, G Sanacora
Nature Reviews Neuroscience 13 (1), 22-37, 2012
15642012
Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications
S Sen, R Duman, G Sanacora
Biological psychiatry 64 (6), 527-532, 2008
14742008
Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
RS Duman, GK Aghajanian, G Sanacora, JH Krystal
Nature medicine 22 (3), 238-249, 2016
13762016
Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders
G Sanacora, G Treccani, M Popoli
Neuropharmacology 62 (1), 63-77, 2012
11462012
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
G Sanacora, CA Zarate, JH Krystal, HK Manji
Nature reviews Drug discovery 7 (5), 426-437, 2008
10572008
Subtype-specific alterations of γ-aminobutyric acid and glutamatein patients with major depression
G Sanacora, R Gueorguieva, CN Epperson, YT Wu, M Appel, ...
Archives of general psychiatry 61 (7), 705-713, 2004
9982004
Reduced cortical γ-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy
G Sanacora, GF Mason, DL Rothman, KL Behar, F Hyder, OAC Petroff, ...
Archives of general psychiatry 56 (11), 1043-1047, 1999
7801999
Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments
RS Duman, G Sanacora, JH Krystal
Neuron 102 (1), 75-90, 2019
6722019
Reduced brain serotonin transporter availability in major depression as measured by [123I]-2β-carbomethoxy-3β-(4-iodophenyl) tropane and single photon emission computed tomography
RT Malison, LH Price, R Berman, CH van Dyck, GH Pelton, L Carpenter, ...
Biological psychiatry 44 (11), 1090-1098, 1998
6381998
Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments
JH Krystal, G Sanacora, H Blumberg, A Anand, DS Charney, G Marek, ...
Molecular psychiatry 7 (1), S71-S80, 2002
6282002
The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis
ST Wilkinson, ED Ballard, MH Bloch, SJ Mathew, JW Murrough, A Feder, ...
American journal of psychiatry 175 (2), 150-158, 2018
5842018
Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors
G Sanacora, GF Mason, DL Rothman, JH Krystal
American Journal of Psychiatry 159 (4), 663-665, 2002
5522002
Increased cortical GABA concentrations in depressed patients receiving ECT
G Sanacora, GF Mason, DL Rothman, F Hyder, JJ Ciarcia, RB Ostroff, ...
American Journal of Psychiatry 160 (3), 577-579, 2003
5312003
Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole
M Banasr, GMI Chowdhury, R Terwilliger, SS Newton, RS Duman, ...
Molecular psychiatry 15 (5), 501-511, 2010
5132010
A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression
JB Singh, M Fedgchin, EJ Daly, P De Boer, K Cooper, P Lim, C Pinter, ...
American Journal of Psychiatry 173 (8), 816-826, 2016
4952016
Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond
JH Krystal, G Sanacora, RS Duman
Biological psychiatry 73 (12), 1133-1141, 2013
4782013
A randomized clinical trial of repetitive transcranial magnetic stimulation in the treatment of major depression
RM Berman, M Narasimhan, G Sanacora, AP Miano, RE Hoffman, XS Hu, ...
Biological psychiatry 47 (4), 332-337, 2000
4662000
A consensus statement on the use of ketamine in the treatment of mood disorders
G Sanacora, MA Frye, W McDonald, SJ Mathew, MS Turner, ...
JAMA psychiatry 74 (4), 399-405, 2017
4512017
Efficacy and safety of intranasal esketamine for the rapid reduction of symptoms of depression and suicidality in patients at imminent risk for suicide: results of a double …
CM Canuso, JB Singh, M Fedgchin, L Alphs, R Lane, P Lim, C Pinter, ...
American journal of psychiatry 175 (7), 620-630, 2018
4502018
Inflammation, glutamate, and glia: a trio of trouble in mood disorders
E Haroon, AH Miller, G Sanacora
Neuropsychopharmacology 42 (1), 193-215, 2017
4102017
The system can't perform the operation now. Try again later.
Articles 1–20